Inform Genomics
Boston, US · Founded 2010 · Delaware corporation
Find your way into Inform Genomics
Sign up to see every warm intro you have to Inform Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Inform Genomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
EB
Edward B RubensteinCEO and President
CD
Carl de MoorChief Technical Officer
SS
Steve SonisNamed on SEC filing
Board
RT
Reed TucksonBoard director
WJ
William JordanBoard director
AJ
Andrew J. FerraraBoard director
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 1 of 4 rounds · 2014–2016
▶$1.5MofferedNov 2016 · BiotechnologyRule 506(b)
▶$1.5MofferedNov 2016 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward B RubensteinExecutive Officer, Director, Promoter
- Andrew FerraraDirector
- William ShieldsExecutive Officer, Director
- Reed TucksonDirector
- William JordanDirector
- Offering amount
- $1.5M
- Proceeds to insiders
- $260K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.2MofferedOct 2015 · BiotechnologyRule 506(b)
▶$8.2MofferedOct 2015 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Reed TucksonDirector
- Andrew FerraraDirector
- Edward B RubensteinExecutive Officer, Director, Promoter
- Carl de MoorExecutive Officer
- William JordanDirector
- Steve SonisDirector
- Offering amount
- $8.2M
- Minimum investment
- $250K
- Proceeds to insiders
- $6.1M
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
▶$1.3MofferedOct 2015 · BiotechnologyRule 506(b)
▶$1.3MofferedOct 2015 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steve SonisDirector
- Edward B RubensteinExecutive Officer, Director, Promoter
- Andrew FerraraDirector
- William JordanDirector
- Carl de MoorExecutive Officer
- Reed TucksonDirector
- Offering amount
- $1.3M
- Proceeds to insiders
- $610K
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
▶$1.7MraisedJan 2015 · 15 investors · BiotechnologyRule 506(b)
▶$1.7MraisedJan 2015 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward B RubensteinExecutive Officer, Director, Promoter
- Steve SonisDirector
- Carl de MoorExecutive Officer
- Reed TucksonDirector
- William JordanDirector
- Andrew J. FerraraDirector
- Offering amount
- $2.6M
- Amount sold
- $1.7M
- Proceeds to insiders
- $600K
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Inform Genomics raised?
- Inform Genomics has disclosed $1.7M raised across 1 of its 4 known rounds.
- Where is Inform Genomics headquartered?
- Inform Genomics is headquartered in Boston, US.